326 related articles for article (PubMed ID: 20428829)
1. HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells.
Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yamauchi J; Natsume H; Moriwaki H; Kozawa O
Oncol Rep; 2010 Jun; 23(6):1709-14. PubMed ID: 20428829
[TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
3. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
[TBL] [Abstract][Full Text] [Related]
4. UVC radiation induces downregulation of EGF receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells.
Yamauchi T; Adachi S; Yasuda I; Nakashima M; Kawaguchi J; Nishii Y; Yoshioka T; Okano Y; Hirose Y; Kozawa O; Moriwaki H
Radiat Res; 2011 Nov; 176(5):565-74. PubMed ID: 21692654
[TBL] [Abstract][Full Text] [Related]
5. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
7. p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047.
Adachi S; Natsume H; Yamauchi J; Matsushima-Nishiwaki R; Joe AK; Moriwaki H; Kozawa O
Cancer Lett; 2009 May; 277(1):108-13. PubMed ID: 19138820
[TBL] [Abstract][Full Text] [Related]
8. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 modulates human sperm capacitation via the Erk1/2 and p38 MAPK signaling pathways.
Sun P; Wang Y; Gao T; Li K; Zheng D; Liu A; Ni Y
Reprod Biol Endocrinol; 2021 Mar; 19(1):39. PubMed ID: 33663544
[TBL] [Abstract][Full Text] [Related]
10. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
Yasui H; Hideshima T; Ikeda H; Jin J; Ocio EM; Kiziltepe T; Okawa Y; Vallet S; Podar K; Ishitsuka K; Richardson PG; Pargellis C; Moss N; Raje N; Anderson KC
Br J Haematol; 2007 Feb; 136(3):414-23. PubMed ID: 17173546
[TBL] [Abstract][Full Text] [Related]
11. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins.
Shimamura T; Lowell AM; Engelman JA; Shapiro GI
Cancer Res; 2005 Jul; 65(14):6401-8. PubMed ID: 16024644
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
14. Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells.
Wu WC; Wu MH; Chang YC; Hsieh MC; Wu HJ; Cheng KC; Lai YH; Kao YH
Exp Eye Res; 2010 Aug; 91(2):211-9. PubMed ID: 20493187
[TBL] [Abstract][Full Text] [Related]
15. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
[TBL] [Abstract][Full Text] [Related]
16. Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex.
Deb TB; Zuo AH; Wang Y; Barndt RJ; Cheema AK; Sengupta S; Coticchia CM; Johnson MD
Am J Physiol Cell Physiol; 2011 May; 300(5):C1139-54. PubMed ID: 21325639
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts.
Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094
[TBL] [Abstract][Full Text] [Related]
18. Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.
Mo Q; Zhang Y; Jin X; Gao Y; Wu Y; Hao X; Gao Q; Chen P
Tumour Biol; 2016 Nov; 37(11):14745-14755. PubMed ID: 27629142
[TBL] [Abstract][Full Text] [Related]
19. HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.
Ghadban T; Dibbern JL; Reeh M; Miro JT; Tsui TY; Wellner U; Izbicki JR; Güngör C; Vashist YK
Apoptosis; 2017 Mar; 22(3):369-380. PubMed ID: 27878398
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
